Structural genomics of the human dopamine receptor system

Area of Science:

• Neuroscience and Pharmacology
• Structural Biology

Background:

• The dopaminergic system, comprising five dopamine receptors (D1R-D5R), is crucial for central nervous system (CNS) functions.
• Dopamine receptor ligands are vital for treating neuropsychiatric disorders like Parkinson's Disease (PD) and schizophrenia.

Purpose of the Study:

• To determine the cryo-electron microscopy (cryo-EM) structures of all five human dopamine receptor subtypes.
• To elucidate the structural basis of rotigotine recognition, polypharmacology, and selectivity.
• To uncover mechanisms of dopamine receptor activation and G protein coupling specificity.

Main Methods:

• Cryo-electron microscopy (cryo-EM) to resolve structures of dopamine receptors bound to G protein and rotigotine.
• Functional assays to analyze ligand polypharmacology and selectivity.
• Structural analysis to understand receptor activation and G protein coupling.

Main Results:

• Reported the first cryo-EM structures of all five human dopamine receptor subtypes complexed with G protein and the pan-agonist rotigotine.
• Revealed the structural basis for rotigotine binding across different dopamine receptor subtypes.
• Identified key determinants of ligand polypharmacology and selectivity, alongside receptor activation mechanisms and G protein coupling specificity.

Conclusions:

• The determined structures provide comprehensive templates for designing specific ligands targeting the dopaminergic system.
• This work facilitates the rational design of novel therapeutics for CNS diseases, including Parkinson's Disease and schizophrenia.
• Understanding dopamine receptor subtypes, activation, and G protein coupling is key for developing precise treatments.